NOV 18, 2020 9:00 AM PST

Choosing an NGS workflow: What are you looking for?

SPONSORED BY: Roche Sequencing

It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While cost and turnaround time are important considerations, the most import question is: What are you trying to learn from your samples? Here, we provide an overview of three general categories of NGS workflows—whole-genome sequencing (WGS), whole-exome sequencing (WES), and target enrichment using custom panels—and the types of information that each provides.

WGS, as its name implies, yields sequence data across the entire genome—which, for humans, contains ~3.1 million base pairs. This includes (a) protein-coding regions, comprising ~1–3% of the genome (the exome), and (b) the rest of the genome, including intergenic and regulatory regions, intron sequences, and regions corresponding to noncoding RNAs. 

WGS can identify genetic variants in coding and noncoding regions, including insertions and deletions (indels), chromosomal rearrangements, copy number variations (CNVs), and single-nucleotide polymorphisms (SNPs). WGS also provides the basis for genome-wide association studies (GWAS), used for finding associations between genetic variants and particular traits or diseases. Unlike many targeted approaches, WGS can also identify variants that change mRNA splicing patterns or that impact the expression of noncoding RNAs, many of which have critical cellular functions. 

While WGS is the most comprehensive and least biased of the workflows discussed here, it requires the greatest amount of sequencing (which is expensive) and the most intensive analysis (which is time-consuming and requires specialized expertise). In addition, because the data from WGS spans the entire genome, it typically does not achieve the depth of sequencing required to answer questions about somatic mutations or rare variants.

WES is a more focused method that primarily captures regions that encode proteins, though some WES panels also include regulatory regions. This selection process is called target enrichment, and is typically carried out during sample preparation using biotinylated probes complementary to the desired sequences (an exome panel, for WES).

Because the majority of known disease-associated variants occur within coding regions, WES is often used to detect these mutations. Compared to WGS, WES greatly reduces sequencing costs by focusing on only ~1–5% of the genome. Thus, for researchers whose focus is protein-coding regions, WES offers a cost-effective alternative to WGS by enabling deeper sequence coverage of target regions and simplifying data analysis. 

When choosing between WGS and WES, it is important to remember that (1) WES data includes only genome regions covered by the exome panel, thus limiting the discovery of variants in other regions and the detection of structural variants, and (2) even the best target enrichment workflows are prone to some degree of target dropout and coverage bias, especially in GC- or AT-rich regions—although well-designed, high-quality probe panels can greatly reduce these issues. 

Targeted and custom-designed probe panels offer an efficient way to gain genetic insights into specific biological processes or disorders. These panels cover highly curated combinations of genomic regions, and can be designed to include a combination of coding and noncoding regions and/or genes associated with particular conditions—such as specific cancers, metabolic disorders, and neurological or cardiac disorders. Custom panels can also target the genomes of other organisms; for example, targeted NGS of bacteria, fungi, and viruses enables the detection of these pathogens in complex samples where the majority of the nucleic acids is from the host.

Although these smaller panels ensure that most of the sequencing resources are devoted to the specific research question, their success depends on many factors, including expert probe design and high-quality probes, as noted above for WES. 

In the end, the research question itself is the best guide for choosing the NGS workflow.
 

 

 

 

 

About the Sponsor
  • At Roche Sequencing, we are building on Roche's legacy of innovation to transform NGS and its application. By simplifying workflows & expanding assay menus, we are broadening access to genomic data & lowering barriers to routine use. Our growing suite of products spans the genomics workflow, from sample acquisition & preparation through data analysis and final result, helping you answer important questions in genetics, cancer & beyond.
You May Also Like
JUN 20, 2021
Genetics & Genomics
Revealing Epigenetic Causes of Type 1 Diabetes
JUN 20, 2021
Revealing Epigenetic Causes of Type 1 Diabetes
Our bodies have to regulate the level of glucose, or sugar, in the blood. The hormone insulin, produced by beta cells in ...
JUL 20, 2021
Cell & Molecular Biology
Do Phages Drive Bacterial Evolution?
JUL 20, 2021
Do Phages Drive Bacterial Evolution?
Antibiotics are a standard treatment for bacterial infections, but more and more of these bacterial infections can't be ...
JUL 26, 2021
Genetics & Genomics
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
JUL 26, 2021
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
Many types of cells have to be replenished continuously throughout our lives, and the genome in the nucleus of those cel ...
JUL 27, 2021
Drug Discovery & Development
Immune related genes influence antipsychotic-induced weight gain.
JUL 27, 2021
Immune related genes influence antipsychotic-induced weight gain.
Mental disorders such as Schizophrenia and Bipolar disorder are currently incurable, but some symptoms can be treated wi ...
AUG 04, 2021
Cell & Molecular Biology
Consuming Too Much Sugar Could Disrupt the Cell's Powerhouses
AUG 04, 2021
Consuming Too Much Sugar Could Disrupt the Cell's Powerhouses
Both processed and prepared foods often contain high levels of sugar. It's thought that the average American eats almost ...
AUG 10, 2021
Microbiology
The CDC Investigates Several Cases of a Rare Tropical Disease
AUG 10, 2021
The CDC Investigates Several Cases of a Rare Tropical Disease
The bacterium Burkholderia pseudomallei is a pathogen that can live in water and soil, usually in tropical parts of nort ...
Loading Comments...